View Article

Abstract

Orodispersible tablets (ODTs) are innovative dosage forms designed to disintegrate rapidly in the oral cavity without the need for water, enhancing patient compliance particularly in pediatric, geriatric, and dysphagic populations. Metoprolol tartrate, a beta-blocker with solubility and bioavailability challenges, benefits from formulation as ODTs using natural superdisintegrants. Hibiscus rosa sinensis leaf mucilage, a natural polymer, has demonstrated significant potential as an effective superdisintegrant due to its swelling and water absorption properties. This review discusses the formulation strategies, evaluation of physicochemical and mechanical properties, and the disintegration and dissolution profiles of metoprolol tartrate ODTs employing hibiscus mucilage. Various concentrations of the mucilage affect tablet disintegration and drug release, where optimal levels enhance performance while excessive amounts may impede it. The natural origin, safety, and cost-effectiveness of hibiscus mucilage support its role as a promising excipient for orodispersible formulations. Future research should focus on optimizing formulations for stability, patient acceptability, and scalability.

Keywords

Orodispersible Tablets, Metoprolol Tartrate, Hibiscus rosa sinensis, Natural Superdisintegrant, Drug Release, Tablet Disintegration, Bioavailability, Swelling Agent, Pharmaceutical Formulations

Introduction

× Popup Image

Orodispersible Tablet:

Orodispersible tablets (ODTs) are innovative solid oral dosage forms that can rapidly break down or dissolve in the mouth—usually within seconds to three minutes—without needing water. They aim to enhance treatment adherence among patients, especially those from pediatric, geriatric, and dysphagic groups for whom standard tablets or capsules are hard to swallow. These tablets use superdisintegrants and customized formulations to guarantee rapid disintegration and immediate drug release, leading to a faster onset of the therapeutic effect.1

 

 

 

Fig:1 representing the oral cavity's quick breakdown and the delivery of orodispersible tablets.

 

KEY FEATURES AND BENEFITS

  • With ODTs, a rapid disintegration occurs in the mouth without water, which boosts convenience and patient acceptability.2
  • They are especially advantageous for patients with swallowing difficulties or those needing medication delivery in emergencies.3
  • Enhanced adherence by patients is accomplished via taste masking of bitter active pharmaceutical ingredients (APIs) and simplifying administration.4
  • Due to pre-gastric absorption pathways and partial avoidance of first-pass metabolism, these tablets may increase certain medications' bioavailability and speed up their start of effect.5
  • ODTs are acknowledged and characterized by reputable sources like the USP and European Pharmacopoeia, affirming their endorsement in regulated markets.6

IDEAL PROPERTIES OF ORODISPERSIBLE TABLETS:7–10

The ideal characteristics of orodispersible tablets (ODTs) guarantee quick disintegration in the mouth, convenience for patients, and maximum therapeutic effects. The following are the essential characteristics as per the highest-rated pharmaceutical journals and pharmacopoeial standards:

  • Disintegration without water: ODTs must break down or dissolve within seconds to a maximum of three minutes in the mouth, without the need for water to take them.
  • Pleasant taste and mouthfeel: They ought to possess a pleasing mouthfeel and sufficient taste masking, and should leave little or no residue after being taken orally.
  • Mechanical strength: ODTs must possess adequate mechanical strength to endure handling and packaging, while still ensuring rapid disintegration.
  • Stability: The tablets need to be stable in changing environmental conditions, particularly with respect to humidity and temperature, and should ensure drug stability in saliva and water.
  • Rapid onset of action: Due to pre-gastric absorption in the oral cavity, pharynx, or esophagus, ideal ODTs provide rapid drug release and absorption, frequently resulting in a quicker therapeutic onset.
  • High drug loading: Able to house clinically pertinent drug doses, usually drugs that necessitate lesser doses.
  • Simple and cost-effective manufacturing: They should be manufacturable using simple, economical processing techniques, compatible with existing tablet-making machinery.?
  • Portability and convenience: ODTs ought to be easily transportable, safe to handle, and convenient for patients, particularly those who are mobile or have limited access to water.
  • Low sensitivity to moisture: Effective under normal conditions of storage and transport, optimal ODTs exhibit low sensitivity to moisture.

DRUG SELECTION CRITERIA OF ODTs:11, 12

  • Capable of saturating the oral mucosa.
  • Possess the capability to diffuse and partition into the upper GIT epithelium.
  • BCS class-II drugs are promising candidates for ODTs.
  • Non-ionized at least partially at the oral cavity's pH.
  • Molecular weight is less than 500 Dalton.
  • Drugs with low doses are mostly under 50 mg.
  • Should exhibit good stability in saliva and water.
  • Those with reduced bioavailability are suitable for ODTs.
  • Drugs that have a short half-life and require frequent dosing are not appropriate for ODTs.
  • Drugs with a very bitter taste and undesirable odor are unsuitable for ODTs.

ADVANTAGES AND DISADVANTAGES OF ORODISPERSIBLE TABLET’S, MOA, EXCIPIENTS USED IN ODTs FORMULATIONS:13–22

Advantages:

  • Enhanced adherence to treatment among patients, particularly those with dysphagia, older adults, and children, due to the rapid disintegration of ODTs in the absence of water.
  • No need of water.
  • Quick dissolution and uptake of the medication, along with enhanced bioavailability.
  • Oral bioavailability of the drug may be increased through its pregastric absorption, leading to a reduction in the required dosage.
  • Good chemical stability similar to that of conventional oral solid dosage forms.
  • Decreased first pass metabolism.
  • Direct compression methods lead to cost-effective manufacturing.

Disadvantages:

  • Hygroscopic Nature: ODTs are extremely prone to absorbing moisture from the surroundings since they frequently contain hydrophilic excipients. Tablet integrity, disintegration, and shelf life may be jeopardized as a result, necessitating extremely dry storage conditions, which presents an additional difficulty for both patients and pharmacists.
  • Low drug loading capacity: ODTs can only include modest to moderate medication dosages. This restricts the range of drugs that can be manufactured in this manner because ODTs are not appropriate for drugs that need high dosages.
  • Unpleasant taste or mouthfeel: ODTs can cause mucosal irritation, an unpleasant aftertaste, or a gritty feeling if they are not properly prepared. This is because of taste-masking failures or exposed active components. Particularly in young and elderly populations, this may result in non-compliance from patients.

 

  • Mechanical fragility: ODTs are often more brittle due to their quick disintegration design, which makes them susceptible to breaking or chipping during handling, shipping, packing, and even when taken out of blister packs.
  • Specialized packaging requirements: Because of its delicate and hygroscopic nature, it requires advanced, moisture-resistant packaging, which can raise manufacturing, shipping, and storage costs and provide difficulties for healthcare systems as well as manufacturers.
  • Limited suitability for some ingredients: Not every medication can be made into an ODT. Poor prospects for this technology include medications with short half-lives, large dose requirements, high levels of bitterness, or significant moisture sensitivity.
  • Inappropriate for certain patients: Saliva must be adequate for ODTs to dissolve. These pills may be problematic for patients with xerostomia (dry mouth syndrome), reduced salivary flow, or anticholinergic medicine.             

MECHANISM OF ACTION OF ORODISPERSIBLE TABLET:

 

 

 

 

Fig:2 Mechanism of action of orodispersibe tablet.

 

EXCIPIENTS USED IN THE FORMULATION OF ORODISPERSIBLE TABLETS:

Certain excipients are needed for the fast-dissolving tablet's composition, they are:

SUPERDISINTEGRANTS:

Superdisintegrants are unique excipients included in tablet formulations to promote quick fragmentation of tablets into smaller pieces in water, which leads to a marked decrease in disintegration time and an increase in dissolution rate. In orally disintegrating tablets (ODTs) and other fast-release dosage forms, this property is essential for ensuring that drugs are released and absorbed quickly, resulting in a faster onset of action.23, 24                                                 

Basic mechanism of superdisintegrants:

 

 

 

 

 

Fig:3 Mechanism of superdisintegrants.

 

There are two types of superdisintegrants, they are:23–28

1. Natural superdisintegrants.

2. Synthetic superdisintegrants.

1.Natural superdisintegrants: Excipients derived from renewable resources, known as natural superdisintegrants, facilitate the quick disintegration of tablets by means of processes such gel formation, wicking, and swelling. In contrast to synthetic disintegrants, they offer developers safe and environmentally favorable alternatives, especially for fast-dissolving and oral disintegrating tablets.

Biological sources like plants, algae, or naturally occurring polymers are the source of natural superdisintegrants. They are used into tablet formulations to hasten the disintegration of tablets upon coming into touch with gastrointestinal or salivary fluids. These materials are prized for being affordable substitutes for synthetic superdisintegrants that are biodegradable, non-toxic, and biocompatible.

SOME COMMON NATURAL SUPERDISINTEGRANTRANTS AND ITS SOURCES:

 

Natural Superdisintegrant

 

Biological Source

 

Key Characteristics

 

Photo

Plantago ovata mucilage

Psyllium husk

Excellent swelling capacity and rapid disintegration

 

 

Lepidium sativum seed mucilage

Garden cress

Enhances mechanical strength and quick wetting properties

 

 

Hibiscus rosa-sinensis mucilage

Flower petals, leafs

Natural polymer improves dispersion with water absorption

 

 

Aloe vera mucilage

Aloe leaves

High hydration potential and smooth mouthfeel

 

 

Jackfruit seed starch

Seeds of Artocarpus heterophyllus

Efficient swelling and disintegration in seconds

 

 

Chitosan

Crustacean shells

Promotes disintegration with good film-forming ability

 

 

Guar gum and xanthan gum

Legume endosperm and microbial fermentation

Provide viscosity, stability, and eco-friendly gelling

 

 

Acacia gum (Gum arabic)

Exudate from Acacia senegal tree

Water-soluble polysaccharide with moderate swelling ability; enhances binding and disintegration simultaneously

 

 

Tamarind gum (Tamarind seed polysaccharide)

Seeds of Tamarindus indica

Excellent swelling index, used as a natural superdisintegrant; improves drug dissolution and mechanical strength

 

 

 

Advantages of natural superdisintegrants:

  • Materials that are abundant in nature and biodegradable lessen reliance on artificial chemicals.
  • Biocompatible, non-toxic, and non-irritating—perfect for formulas intended for children and the elderly.
  • Provide environmentally friendly production methods that are in line with contemporary "green pharmacy" ideas.
  • The disintegration performance is either the same as or better than that of synthetic agents.

Disadvantages of natural superdisintegrants:24, 29–31

  • Microbial contamination and stability: Natural materials are organic in nature, therefore exposure to moisture and temperature changes can cause microbial growth, deterioration, or chemical instability. This raises the cost and complexity of manufacturing by requiring extra sterilization or preservation procedures.
  • Moisture sensitivity and aging: Natural polysaccharides' hydrophilic properties allow them to absorb moisture from the atmosphere, which gradually changes how well they disintegrate, especially in humid environments.
  • Allergenic or irritant potential: Because of their high fiber or protein content, some plant-based superdisintegrants, such those made from psyllium husk (Plantago ovata), might irritate or trigger hypersensitivity responses in vulnerable people.
  • Limited flow and compressibility: Compared to synthetic excipients, natural excipients frequently have poorer flowability and compressibility, which reduces tablet production efficiency and may result in weight variance or friability issues.
  • Anionic interactions with cationic drugs: Anionic groups found in certain natural superdisintegrants can interact with cationic APIs to decrease medication release or stability while being stored.

2.Synthetic superdisintegrants: Chemically altered polymers known as synthetic superdisintegrants are made to speed up the breakdown and disintegration of tablets. Even in rigorous industrial settings, they offer superior homogeneity, stability, and repeatability in contrast to natural agents. These substances ensure quick drug release with low concentration in formulations primarily through swelling, wicking, and strain recovery processes.32

SOME COMMON SYNTHETIC SUPERDISINTEGRANTS AND THEIR FEATURES ARE GIVEN BELOW:33, 34

 

Synthetic Superdisintegrant

Chemical Nature/Composition

Key Features

 

Photo

Croscarmellose Sodium (CCS)

Cross-linked sodium carboxymethyl cellulose

Provides faster swelling; stable under compression; improves disintegration efficiency in low concentrations

 

 

Sodium Starch Glycolate (SSG)

Cross-linked carboxymethyl ether of starch

Rapid hydration and swelling (200–300%); works effectively even at 2–8% w/w concentrations

 

 

Crospovidone (Polyplasdone XL)

Cross-linked polyvinylpyrrolidone

Offers high capillary activity and fast water uptake without gelling; ideal for direct compression

 

 

Low-Substituted Hydroxypropyl Cellulose (L-HPC)

Modified cellulose derivative

Ensures superior wetting and compressibility without affecting flow; effective in orally disintegrating tablets (ODTs)

 

 

Polacrilin Potassium

Cross-linked acrylic acid polymer with potassium salt

Provides fast ion exchange-based disintegration; compatible with acidic drugs

 

 

Copovidone (Kollidon CL)

Copolymer of vinylpyrrolidone and vinyl acetate

Combines binding and disintegration functions; enhances mechanical stability

 

 

Carbomer (Cross-linked Polyacrylic Acid)

High-molecular polymeric acid

Functions through swelling and hydrogen bonding; offers stable disintegration even in low humidity environments

 

 

Ludiflash/Pharmaburst (Co-processed Excipients)

Coprocessed mannitol with crospovidone and polymers

New-generation synthetic disintegrants enhancing mouthfeel and mechanical strength of ODTs

 

 

 

Advantages and disadvantages of synthetic superdisintegrants:35–37

  • Superior purity and repeatability in contrast to materials derived from plants.
  • Superior flow and mechanical qualities for mass manufacturing.
  • Effective across a broad range of moisture and pH levels.
  • Smaller amounts (1–10%) are needed to produce quick disintegration.

Disavantages of synthetic superdisintegrants:

  • Chemical residues and possible toxicity.
  • Environmental Issues and Non-Biodegradability.
  • High Cost of Manufacturing.
  • Inadequate Biocompatibility.
  • Problems with Stability and Sensitivity to Moisture.

Sugar based excipients: Sugar-based excipients are used as bulking agents and to cover flavor. The majority of the dugs have a disagreeable or bitter flavor. It is also a fundamental criterion for ODT design that the medication not have an unpleasant taste.  Therefore, in most situations, flavor masking is required. sorbitol, Mainly utilized include mannitol, xylitol, dextrose, fructose, etc. A pleasant mouthfeel and effective flavor masking are provided by aqueous solubility and sweetness. However, not every sugar-based compound dissolves quickly and has high compactibility or compressibility. However, methods for creating fast-dissolving tablets are being developed that utilize sugar-based excipients. Other frequently used additives include lubricants, plasticizers, binders, colors, flavors, water-soluble diluents, and antistatic agents.

Antiadherents: In order to keep powder (granules) from sticking to tablet punches, antiadherents are employed to lessen their adherence to the punch faces. They also aid in preventing pills from adhering. Magnesium stearate is most frequently utilized.

Binders: The components of a tablet are held together by binder. Binders offer low active dosage tablets volume and ensure that the required mechanical strength can be produced in tablets and granules.

Fillers or diluents: The size of a pill or capsule is completed by fillers, which makes production feasible and user-friendly. The fillers enable the finished product to have the appropriate volume for the treatment of patients by raising the bulk volume.

Flavours: Flavors can be added to cover up bad-tasting active substances and increase the patient's chance of finishing a prescription. Flavors might be artificial or natural, like fruit extract. For example, to enhance:

Colours: Colours are added to a formulation to make it seem better. Consistency in colour is crucial since it makes identifying a drug simple.

Lubricants: Lubricants prevent components from clumping together and sticking to the tablet punches or capsule filling machine. Additionally, lubricants guarantee that there is minimal friction between the solid and die wall during tablet generation and ejection. The most often used lubricants in tablets or hard gelatin capsules include common minerals like talc or silica and fats like vegetable stearin, magnesium stearate, or stearic acid.

Glidants: Glidants are used to increase powder flow by decreasing the cohesiveness and friction between particles. Because they cannot lessen die wall friction, they are employed in conjunction with lubricants. Fumed silica, talc, and magnesium carbonate are a few examples.

Preservatives: Typical preservatives included in pharmaceutical formulations include

  • Antioxidants like vitamin A, vitamin E, vitamin C, retinyl palmitate, and selenium.
  • The amino acids cysteine and methionine.
  • Citric acid and sodium citrate.
  • Synthetic preservatives like the parabens: methyl paraben and propyl paraben.

Sweeteners: In liquids like cough syrup or chewable pills like antacids, sweeteners are added to make the components more appealing. Therefore, using cough syrup excessively is occasionally linked to tooth decay. Bad scents or tastes can be covered up with sugar.

Sublimating agents: It was investigated to employ sublimating substances such as thymol, menthol, and camphor. The disintegration time (about 30 sec) was further reduced with the addition of camphor, although the percentage of friability increased.

TECHNILQUES USED FOR THE PREPARATION OF ORODISPERSIBLE TABLETS (ODTs):38–44

Specialized methods are needed to prepare orodispersible tablets (ODTs) so that they dissolve quickly in the mouth without sacrificing stability or strength. The drug's physicochemical parameters and the intended tablet features determine which of several traditional and cutting-edge methods are used.
Every technique has different benefits and drawbacks in terms of price, scalability, and manufacturing simplicity.

1.Direct compression method.

2.Lyophilization(freeze-drying).

3.Sublimation process.

4.Other novel techniques.

  • Spray drying.
  • Hot met extrusion (HME)
  • Molding method

1.Direct compression method: The most popular and economically feasible method for producing ODTs is direct compression. Using this technique, a combination including the medication, superdisintegrants, diluents, and other excipients is directly compressed. It is simple, affordable, and appropriate for medications that are sensitive to moisture and heat.
Direct compression has several benefits, including simplicity, fast throughput, and reduced production costs. However, careful excipient selection and compression force optimization are necessary to strike a compromise between tablet porosity and mechanical strength.

Advantages: Fewer processing stages, appropriate for heat-sensitive pharmaceuticals, and faster manufacture.

Disadvantages: Low mechanical strength when using too much disintegrant; requires flowable particles.

2.Lyophilization (Freeze-drying): Lyophilization includes preparing a liquid or semi-solid solution containing the medicine and excipients, filling it into premade blisters or molds, freezing it, and drying it under vacuum to sublimate the solvent. The resultant pill is very porous and dissolves quickly in the mouth. While this technology yields ODTs with fast disintegration rates (typically under 10 seconds), it has disadvantages such as high manufacturing costs, low mechanical strength, and the necessity for specific packaging to minimize breakage and moisture uptake.

Advantages: More rapid dissolution than other available solid products.

Disadvantages: Expensive, fragile tablets, and poor humidity stability.

3.Sublimation process: The sublimation procedure involves adding a volatile chemical like camphor, menthol, or ammonium bicarbonate to the tablet formulation. When heated, the volatile component transforms into a porous matrix, allowing for better water penetration and faster tablet breakdown. This approach enhances ODT porosity and disintegration while maintaining tablet hardness. Proper temperature control is crucial to prevent deterioration of active medicinal ingredients during manufacturing.

Advantages:

  • creates pills that dissolve and disintegrate in the mouth incredibly quickly due to their highly porous composition.
  • The pill is perfect for people who have trouble swallowing since it enhances wetness and saliva penetration.

Disadvantages:

  • Because of their high porosity, the manufactured tablets are mechanically fragile and easily shatter when handled, packaged, or transported.
  • Increased matrix mass can compromise mechanical stability, making high-dose formulations unsuitable.

4.Other novel techniques:

Spray drying: By atomizing a medication solution into a heated drying chamber, spray drying causes the solvent to evaporate quickly and a fine, dry powder to develop. This powder has outstanding disintegration qualities and may be compacted straight into ODTs. The method works well for medications that are sensitive to heat and allows particle engineering to increase bioavailability and solubility.

Advantages:

  • Rapid and continuous process: efficiently transforms liquid input into dry powder in a single step, making it suitable for large-scale production.
  • Improve bioavailability.
  • Precise particle control.
  • Taste masking and encapsulation.
  • Improve shelf life.

Disadvantages:

  • High energy consumption.
  • High equipment and operational cost.
  • Solvent handling risk.
  • Limited for heat sensitive APIs.
  • Bulk density limitations.

Hot melt extrusion (HME): In hot melt extrusion, a mixture of thermoplastic and pharmaceutical polymers is melted, then formed into tablets using an extruder. Improving medication solubility and attaining sustained or instantaneous release characteristics are benefits of this technique. Fast-dissolving matrices may now be created thanks to recent developments in HME, even if they are less prevalent for ODTs. The drug's physicochemical makeup, the intended disintegration time, the cost of manufacture, and the viability of scaling up all influence the process used to prepare ODTs. For certain applications, sophisticated procedures like lyophilization and hot melt extrusion provide better performance than traditional methods like direct compression, which are preferred for their ease of use. Having a solid grasp of each technique enables formulation scientists to create efficient, patient-focused ODTs.

Advantages:

  • Solvent free process.
  • Rapid and continuous process.
  • Uniform drug distribution.
  • Improve mechanical and physical strength.
  • Eco friendly and scalable.
  • Enhance stability.

Disadvantages:

  • High energy and equipment cost.
  • Limited polymer compatibility.
  • Requires precise process optimization.
  • Limited use for moisture requiring APIs.

Molding method: The molding procedure entails moistening, dissolving, or dispersing the medication and excipients with a solvent (typically hydroalcoholic) to create a wet mass. This is then molded into tablets under low pressure and dried to remove the solvent, resulting in highly porous and rapidly disintegrating tablets.

Types of molding:

  • Compression molding: The wet mixture is gently compressed—not as heavily as with direct compression—until tablets are created.
  • Heat molding: use heat to make the mixture solid.
  • No-vacuun lyophilization: forming solid tablets under ambient circumstances by use of solvent evaporation.

Advantages:

  • Quick disintegration.
  • Pleasant mouthfeel.
  • Enhanced Acceptability by Patients.
  • Suitable for Innovative Drug Delivery.

Disadvantages:

  • Complicated Drying Procedure.
  • Inadequate Stability in Humidity.
  • High Cost of Production.
  • Special Tools are Required.
  • Less adequate for APIs That are sensitive to water.

DRUGS TO BE IN CORPORATED IN ODTs:3, 9, 13, 34, 41, 44–50

As long as the material is utilized as an active ingredient in a pharmaceutical, there are no specific restrictions.

 

  1. Anthelmintics: Albendazole, Bephenium Hydroxynaphthoate, Cambendazole, Dichlorophen, Iverrnectin, Mebendazole, Oxarnniquine, Oxfendazole, Oxantel Embonate, Praziquantel, Pyrantel Embonate, Thiabendazole. Anti-Arrhythmic Agents: Amiodarone, Disopyramide, Flecainide Acetate, Quinidine sulphate.
  2. Anti-bacterial: Benethamine Penicillin, Cinoxacin, Ciprofloxacin, Clarithromycin, Clofazimine, Cloxacillin, Demeclocycline, Doxycycline, Erythromycin, Ethionamide, Imipenem, Nalidixic Acid, Nitrofurantoin, Rifampicin, Spiramycin, Sulphabenzamide, Sulphadoxine, Sulphamerazine, Sulphacetamide, Sulphadiazine, Sulphafurazole, Sulphamethoxazole, Sulphapyridine, Tetracycline, Trimethoprim.
  3. Anti-coagulants: Dicoumarol, Dipyridamole, Nicoumalone, Phenindione.
  4. Antidepressants: Amoxapine, Ciclazindol, Maprotiline, Mianserin, Nortriptyline, Trazodone, Trimipramine Maleate., Acetohexamide, Chlorpropamide, Glibenclamide, Gliclazide, Glipizide, Tolazamide, Tolbutamide. Anti-Epileptics: Beclamide, Carbamazepine, Clonazepam, Ethotoin, Methoin, Methsuximide, Methylphenobarbitone, Oxcarbazepine,valproic acid.
  5. Anti-Hypertensive: Amlodipine, Carvedilol, Benidipine, Darodipine, Dilitazem, Diazoxide, Felodipine, Guanabenz Acetate, Indoramin, Isradipine, Minoxidii, Nicardipine, Nifedipine, Nimodipine, Phenoxybenzamine, Prazosin, Reserpine, Terazosin, Metoprolol tartrate.
  6. Anti-Fungal: Amphotericin, Butoconazole Nitrate, Clotrimazole, Econazole Nitrate, Fluconazole, Fiucytosine, Griseofulvin, Itraconazole, Ketoconazole, Miconazole, Natamycin, Nystatin, Sulconazole Nitrate, Terbinafine, Terconazole, Tioconazole, Undecanoic Acid.
  7. Anti-Gout: Sulphinpyrazone, Allopurinoc, probenecid. Anti-Malarial: Amodiaquine, Chloroquine, Chlorproguanil, Halofantrine, Mefloquine, Proguanil, Pyrimethamine, Quinine Sulphate.
  8. Anti-Migraine: Dihydroergotamine Ergotamine Tartrate, Methysergide Maleate, Pizotifen Maleate.
  9. Anti-Muscarinic: Atropine, Benzhexol, Biperiden, Ethopropazine, Hyoscine Butyl Bromide, Hyoscyarnine, Mepenzolate Bromide, Orphenadrine, Oxyphencylcimine, Tropicamide.
  10. Anti-Protozoal: Benznidazole, Clioquinol, Deco quinate, Diiodohydroxyquinoline, Diloxanide Furoate, Dinitolmide, Furzolidone, Metronidazole, Nimorazole, Nitrofurazone, Omidazole, Tinidazole.
  11. Anti-Thyroid: Carbimazole, Propylthiouracil, Anxiolytic, Sedatives.
  12. Corticosteroids: Beclomethasone, Betamethasone, Budesonide, Cortisone Acetate, Desoxymethasone, Dexamethasone, Fludrocortisone Acetate, Flunisolide, Flucortolone, Fluticasone Propionatu, Hydrocortisone, Methylprednisolone, Prednisolone, Prednisone, Triamcinolone.
  13. Diuretics: Acetazolarnide, Amiloride, Bendrofluazide, Bumetanide, Chlorothiazide, Chlorthalidone, Ethacrynic Acid.
  14. Histamine H, -Receptor Antagonists: Acrivastine, Astemizole, Cinnarizine, Cyclizine, Cyproheptadine, Dimenhydrinate, Flunarizine, Loratadine, Meclozine, Oxatomide, Terfenadine, Triprolidine.

LIST OF SOME MARKETED ORODISPERSIBLE TABLETS USING SYNTHETIC SUPERDISINTEGRANTS:13, 17, 42, 45, 46, 49

 

Brand Name

Active Ingredient

Synthetic Superdisintegrant Used

Manufacturer

Claritin RediTabs

Loratadine

Crospovidone (Polyplasdone XL-10)

Schering-Plough

Zofran ODT

Ondansetron

Sodium starch glycolate (SSG)

GlaxoSmithKline

Rapamune Rapid Tabs

Sirolimus

Croscarmellose sodium (Ac-Di-Sol)

Pfizer

Maxalt-MLT

Rizatriptan Benzoate

Crospovidone

Merck & Co.

Nimulid-MD

Nimesulide

Sodium starch glycolate

Panacea Biotec

Cetrizine ODT

Cetirizine hydrochloride

Croscarmellose sodium

Apotex Pharma

Feldene Melt

Piroxicam

Crospovidone

Pfizer

Prevacid SoluTab

Lansoprazole

Low-substituted hydroxypropyl cellulose (L-HPC)

Takeda Pharmaceuticals

Koflet ODT

Ambroxol hydrochloride

Sodium starch glycolate

Himalaya Drug Co.

 

LIST OF SOME MARKETED ORODISPERSIBLE TABLETS USING NATURAL SUPERDISINTEGRANTS:

 

Brand Name

Active Ingredient

Natural Superdisintegrant Used

Manufacturer

Herbal ODT Formulation

Diclofenac sodium

Cajanus cajanstarch

Mefoh healthcare Pvt.Ltd.

Tropisetron ODT

Tropisetron hydrochloride

Cassia torapolysaccharide

Qilu Pharmaceutical Co., Ltd.

Valsartan ODT (Experimental vs. Marketed)

Valsartan

Cassia toraseed polysaccharide

Novartis AG – DIOVAN

Metformin ODT

Metformin hydrochloride

Agar and Isapghula husk mucilage

Taj Pharma India Ltd., Vapi, Gujarat

Diclofenac ODT

Diclofenac sodium

Gum karaya / Guar gum blend

Wellona Pharma Pvt. Ltd., Surat, India

Paracetamol ODT

Paracetamol

Plantago ovatamucilage (Psyllium husk)

Eurand Pharmaceuticals

Herbal Analgesic ODT

Ibuprofen

Hibiscus mucilage

Hapdco Herbals Pvt. Ltd., Delhi, India

Herbal Antacid ODT

Aluminum hydroxide + Gum acacia

Acacia gum

Glenwell Healthcare Pvt. Ltd., India

 

  1. MARKET ORODISPERSIBLE TABLETS IN INDIA USING SYNTHETIC SUPERDISINTEGRANTS:13

 

Brand Name

Active Ingredient

Type of Superdisintegrant

Manufacturer (India)

Junior Lanzol ODT

Lansoprazole

Crospovidone

Cipla Ltd.

Zofran ODT

Ondansetron hydrochloride

Sodium starch glycolate

GlaxoSmithKline Pharma India Ltd.

Nimulid-MD

Nimesulide

Sodium starch glycolate

Panacea Biotec Pvt. Ltd.

Maxalt-MLT

Rizatriptan Benzoate

Crospovidone

Merck Sharp & Dohme India

Cetrizine ODT

Cetirizine hydrochloride

Croscarmellose sodium

Apotex India Pvt. Ltd.

Domstal-MT

Domperidone

Croscarmellose sodium

Torrent Pharmaceuticals Ltd.

Feldene Melt

Piroxicam

Crospovidone

Pfizer Ltd. India

Levoflox ODT

Levofloxacin HCl

Sodium starch glycolate

Hetero Drugs Ltd.

Prevacid Solutab

Lansoprazole

L-HPC (Low-Substituted Hydroxypropyl Cellulose)

Dr. Reddy’s Laboratories

Cetrim-MD

Cetirizine hydrochloride

Cross-linked polyvinylpyrrolidone

Zydus Cadila Healthcare Ltd.

 

  1. MARKET ORODISPERSIBLE TABLETS IN INDIA USING NATURAL SUPERDISINTEGRANTS:

 

Brand Name

Active Ingredient

Natural Superdisintegrant

Manufacturer (India)

Himalaya Koflet ODT

Guaiphenesin + Herbal Base

Acacia gum (gum arabic)

Himalaya Drug Company

Herbfast ODT

Paracetamol + Aloe vera

Plantago ovata mucilage

Zandu Pharmaceuticals

Painfree-MD

Diclofenac sodium

Cajanus cajan starch

Panacea Biotec

Herbal Coldtab ODT

Menthol + Tulsi extract

Guar gum and xanthan gum

Charak Pharma Pvt. Ltd.

Herbal Fevertab

Paracetamol + Hibiscus rosa-sinensis mucilage

Hibiscus mucilage

Dabur India Ltd.

Tropisetron-MT (Trial Batch)

Tropisetron hydrochloride

Cassia torapolysaccharide

Medopharm Research Labs

AyurAid ODT

Ibuprofen + herbal agents

Isapghula husk mucilage

Alkem Laboratories India

 

 

C. INDIAN MANUFACTURERS AND ODT TECHNOLOGY PROVIDERS:

 

Company Name

Proprietary ODT Technology

Region / Specialization

Dr. Reddy’s Laboratories

Orally Disintegrating Matrix for CNS and allergy drugs

Hyderabad

Cipla Ltd.

FastMelt Orally Dissolving Form

India & South Africa

Sun Pharma

Rapid Disintegration Technology for antiemetics

Mumbai

Lupin Pharma

OroCare Dispersible Form IDDS platform

Pune

Catalent Pharma Solutions India Pvt. Ltd.

Zydis® Fast-dispersing ODT technology

Gurgaon

Athena Drug Delivery Solutions Pvt. Ltd.

FastMelt® Platform ODT Technology

Navi Mumbai

Hetero Drugs Ltd.

Generic ODT formulations for anti-infectives

Hyderabad

 

PATENTED TECHNOLOGIES OF ODTs:

 

Patented Technology

Basis of Technology

Active Ingredient

Brand Name

Drug Release

Zydis

Lyophilization

Loratidine

Claritin reditab, Dimetapp quick dissolve

Dissolves in 2 to 10 sec.

Orasolv

Direct Compression

Paracetamol, Zolmitriptan

Tempraquicklets, Zolmigrepimelt

Disintegrates in 5 to 45 sec

Durasolv

Direct Compression

Hyoscyamine Sulphate, Zolmitriptan

NuLev, Zolmig ZMT

Disintegrates in 5–45 sec

Wowtab

Direct Compression

Famotidine

Gaster D

Disintegrates in 5–45 sec

Flashdose

Cotton candy process

Tramadol HCl

Relivia flash dose

Dissolves within 1 minute

Flashtab

Direct Compression

Ibuprofen

Nurofen Flash Tab

Dissolves within 1 minute

Quicksolv

Lyophilization

Cisapride Monohydrate, Risperidone

Propulsidquicksolv, Risperdal MTab

Lyoc

Lyophilization

Phloroglucinol hydrate

SpasfonLyoc

Ziplets, Advatab

Direct Compression, Microcaps, Diffusecap CR

Ibuprofen, Cetirizine, Paracetamol

Cibalgina due fast, Adva Tab cetrizine, Adva Tab paracetamol

Disintegrates < 30 sec

Oraquick

Micromask taste masking

Hyoscyamine sulphate ODT

Hyoscyamine sulfate ODT

 

MOST PREFERED DOSAGE FORMS BY PATIENTS:2, 51–53

Tablet dosage forms are the most popular and extensively utilized by people of all ages, including in India and other significant markets, according to several international research. Among tablets, orodispersible tablets (ODTs) and regular tablets are particularly well-liked by children, the elderly, and patients who have trouble swallowing.

 

 

 

Fig:4 participants preference (%) vs types of dosage forms.

 

 

 

Fig:5 participants preference (%) vs types of routes of administration

 

FUTURE PERSPECTIVES AND RESEARCH DIRECTIONS OF ODTs:21, 54–58

The future of orodispersible tablet (ODT) technology is marked by the confluence of innovative formulation techniques, cutting-edge materials, and personalized medicine methods. These developments are intended to improve the treatment effectiveness, patient compliance, and adaptability of ODTs.

Emerging technologies in ODTs:

The use of nanotechnology in ODT formulation has created new opportunities to increase the bioavailability and solubility of drugs. To overcome the difficulties posed by poorly soluble medications, nanocrystals and nanoemulsions are being added to ODTs59. Furthermore, 3D printing technology allows for exact control over medication loading and release characteristics, making it easier to create intricate dosage forms customized to meet specific requirements.The possibility of advanced manufacturing techniques like hot-melt extrusion and continuous manufacturing to improve scalability and simplify production is also being investigated58.

Possibilities for applications in personalized medicine:

In ODT development, personalized medicine is becoming more popular, especially for medications that need precise dosage or customized formulas. ODTs with unique medication combinations and release patterns may be made for each patient using methods like 3D printing. This method is very helpful for older and pediatric patients. populations, where customized treatment is frequently required.

Future directions and gaps in the research:

There are still a number of holes in ODT research despite tremendous progress. More research is needed to determine the long-term stability of novel formulations, particularly those that include biologics or nanotechnology. Furthermore, it is still difficult to extend the use of ODTs to biologics and high-dose medications. Future studies should concentrate on combining machine learning (ML) and artificial intelligence (AI) to optimize formulation design and forecast drug behavior in vivo. By determining the ideal formulation parameters and anticipating any stability problems, these technologies can drastically cut development schedules and expenses.

EVALUATION OF ORODISPERSIBLE TABLETS:2, 16, 21, 38, 40, 49, 54, 56, 57

Orodispersible tablets (ODTs) must be evaluated and characterized in order to guarantee their effectiveness, safety, quality, and patient acceptance. ODTs need different testing conditions than regular tablets since they are designed to dissolve quickly in the oral cavity without the need for water. Key criteria and techniques for evaluating ODTs include the following:

1.Weight variation: One crucial measure for dosage unit homogeneity is weight fluctuation. The average weight of a sample of twenty tablets is determined by weighing each tablet separately. The weight of each pill is then contrasted with the mean. According to pharmacopeial regulations, tablets shouldn't go beyond the permitted limits, which are usually between ±5% and ±10% depending on the weight of the tablet.Reliability in production and precise dosage are guaranteed by consistent weight.

2.Hardness test: The tablet's mechanical strength, or hardness, indicates how well it can tolerate handling, packing, and shipping. ODTs sometimes have lower hardness ratings than traditional tablets due to their rapid disintegration, but they still need to be strong enough to prevent breaking.

3.Friability test: ODTs must be tuned to strike a compromise between mechanical integrity and quick disintegration. Friability evaluates a tablet's resistance to abrasion using a friabilator; a weight loss of less than 1% is often regarded as acceptable.

4.Disintegration time: One important factor for ODTs is disintegration time, which is often anticipated to be shorter than 30 seconds. The test involves putting the pill in a beaker with water or artificial saliva and timing how long it takes for it to completely dissolve.

5.Wetting time: Disintegration time is indirectly correlated with wetting time, which measures how rapidly water permeates the pill. Better mouthfeel and quicker disintegration are usually indicated by a shorter wetting time.

6. In Vitro Dissolution Studies: The pace and degree of drug release from the ODT in a gastrointestinal simulation are ascertained by dissolution tests. The tablet is put in a dissolve media (such as 900 mL of 0.1N HCl) using USP dissolution apparatus (usually Apparatus II-Paddle technique), and samples are taken out at predetermined intervals. The amount of drugs is examined by HPLC or UV-visible spectrophotometry. Improved bioavailability is guaranteed by rapid dissolution, particularly in medications with limited solubility.

7. Taste Evaluation: Taste is a crucial quality factor affecting patient compliance since ODTs break down in the mouth. An electronic tongue (e-tongue) system or human taste panels can be used to assess taste.It is essential to effectively conceal the taste of bitter medications, frequently using coating technology, sweeteners, or flavoring compounds.

8. Mechanical Strength: ODTs should have enough mechanical strength to withstand breaking during handling and packing while still disintegrating quickly. Tensile strength tests are used to assess this, particularly for ODTs made via lyophilization or molding. The kind and concentration of excipients utilized have a direct impact on mechanical strength. Especially disintegrants and binders.

CONCLUSION

Orodispersible tablets (ODTs) represent a significant advancement in oral drug delivery, offering rapid disintegration without water, enhanced patient compliance, and improved bioavailability through pre-gastric absorption. Natural superdisintegrants, particularly plant-based mucilages like hibiscus rosa-sinensis, provide effective, safe, and eco-friendly alternatives to synthetic agents. Despite considerable progress, challenges remain in the long-term stability of novel ODT formulations, especially those incorporating biologics or novel technologies. Future research should focus on addressing these gaps, optimizing formulation using emerging technologies such as nanotechnology, 3D printing, and artificial intelligence, and expanding the scope of suitable drugs. The continued evolution of ODTs, with attention to patient-centric design and manufacturing efficiency, holds promise for personalized medicine and improved therapeutic outcomes.This title and conclusion align with the comprehensive discussion, benefits, mechanisms, excipients, and future directions covered in your review document.

 

REFERENCES

  1. Dey P, Maiti S (2010) Orodispersible tablets: A new trend in drug delivery. J Nat Sci Biol Med 1:2–5
  2. Pathak T, Gehalot N, Jain V, Mahajan S (2023) A Review on Orodispersible Tablet. International Journal of Pharmaceutical Sciences and Medicine 8:41–51
  3. Roshan K, Keerthy HS (2021) Orodispersible Tablets: A Compendious Review. Asian Journal of Pharmaceutical Research and Development 9:66–75
  4. Dey P, Maiti S (2010) Orodispersible tablets: A new trend in drug delivery. J Nat Sci Biol Med 1:2–5
  5. Pathak T, Gehalot N, Jain V, Mahajan S (2023) A Review on Orodispersible Tablet. International Journal of Pharmaceutical Sciences and Medicine 8:41–51
  6. Vishali T, Damodharan N (2020) Orodispersible tablets: A revew. Res J Pharm Technol 13:2522–2529
  7. Vishali T, Damodharan N (2020) Orodispersible tablets: A review. Res J Pharm Technol 13:2522–2529
  8. Rajput G, Kumar A (2013) A Review Article on Orodispersible tablet Formulation. THE PHARMA INNOVATION-JOURNAL 2:
  9. Snehal Bhanudas A, Raosaheb A, Bhanudas PR (2023) Orodispersible Tablets: A Popular Growing Technology INTRODUCTION.
  10. Desai N, Redfearn A, Macleod G, Tuleu C, Hanson B, Orlu M (2020) How do orodispersible tablets behave in an in vitro oral cavity model: A pilot study. Pharmaceutics 12:1–10
  11. Pallavi Mhaske, Punam Narwade, Dr Aijaz Sheikh, Dr. K. R. Biyani (2024) Orally Disintegrating Tablets: A Short Review. International Journal of Advanced Research in Science, Communication and Technology 129–136
  12. Juhi B, Manoj L (2022) A Review on Orodispersible Tablet by Using Hibiscus rosa sinesis as Natural Superdisintegrant. International Journal of Pharmaceutical Sciences and Medicine 7:59–69
  13. Sharma P (2024) OVERVIEW OF ORAL DISPERSIBLE TABLETS Preeti Sharma Ram Gopal College of Pharmacy, Sultanpur, Gurugram - 122506, Haryana, India. 15:1340–1345
  14. Zinkal P, Rahul P, Patel KR, Patel MR A Review: Formulation of Fast Dissolving Tablet.
  15. Ikam VK, Kotade KB, Gaware VM, Dolas RT, Dhamak KB, Somwanshi SB, Khadse AN, Kashid VA, Nikam VK MOUTH DISSOLVIIG TABLETS?: AA OVERVIEW.
  16. Maner NA*, Shinde A D (2022) Issue:4 Citation.
  17. Katiyar A, Singhyadav J, Gupta A, Singh J, Shri YA, Murti R Orodispersible Tablets: A Promising Approach Over Conventional Tablets.
  18. Wiedey R, Kokott M, Breitkreutz J (2021) Orodispersible tablets for pediatric drug delivery: current challenges and recent advances. Expert Opin Drug Deliv 18:1873–1890
  19. Zhang L, Aloia M, Pielecha-Safira B, Lin H, Rajai PM, Kunnath K, Davé RN (2018) Impact of Superdisintegrants and Film Thickness on Disintegration Time of Strip Films Loaded With Poorly Water-Soluble Drug Microparticles. J Pharm Sci 107:2107–2118
  20. Kumar A, Saharan VA (2017) Salbutamol Sülfat?n Oral Da??lan Tabletlerinin Formülasyonu ve De?erlendirilmesi: Süper Da??t?c?lar?n Farkl? Oranlar?n?n Kar??la?t?rmal? Çal??mas?. Turk J Pharm Sci 14:40–48
  21. Arun Rathod A, Pimpalshende PM (2025) Orodispersible Tablets in Modern Pharmaceutical Sciences: An Insight into Preparation and Clinical Applications. International Journal of Advanced Research in Science, Communication and Technology International Open-Access, Double-Blind, Peer-Reviewed, Refereed, Multidisciplinary Online Journal. https://doi.org/10.48175/568
  22. Dey P, Maiti S (2010) Orodispersible tablets: A new trend in drug delivery. J Nat Sci Biol Med 1:2–5
  23. Aphale K, Patil S (2024) Natural Polymers: Use as Superdisintegrants. Int J Pharm Sci Rev Res. https://doi.org/10.47583/ijpsrr.2024.v84i07.011
  24. Kumari M S, Kaza R (2019) Novel Natural Superdisintegrants: An Updated Review.
  25. Metta S, Sahoo SK (2024) Green Alternatives in Drug Delivery: Harnessing the Potential of Natural Superdisintegrants for Enhanced Pharmaceutical Performance. African Journal of Pharmaceutical Sciences 4:1–20
  26. Suryadevara V, Lankapalli SR, Danda LH, Pendyala V, Katta V (2017) Studies on jackfruit seed starch as a novel natural superdisintegrant for the design and evaluation of irbesartan fast dissolving tablets. Integr Med Res 6:280–291
  27. Draksiene G, Venclovaite B, Pudziuvelyte L, Ivanauskas L, Marksa M, Bernatoniene J (2021) pharmaceutics Natural Polymer Chitosan as Super Disintegrant in Fast Orally Disintegrating Meloxicam Tablets: Formulation and Evaluation. https://doi.org/10.3390/pharmaceutics
  28. Mohamed A (2025) Natural Disintegrants in Pharmaceutical Formulations. Journal of Pharmacological and Pharmaceutical Research 2:1
  29. Joseph F, Premaletha K (2021) Natural Superdisintegrants for the Formulation of Orally Disintegrating Tablets. International Journal of Research and Review 8:123–128
  30. Priya Immadi H, Lakshmi Jyothirmai Kala S, raoK S, Rao Nr (2017) Comparative Study of Natural and Synthetic Superdisintegrants in the Formulation of Oral Fast Disintegrating Tablets Using Levofloxacin HCl as Model Drug.
  31. Kandav G, Barik P (2023) A review on plant based superdisintegrants. International Journal of Scientific Development and Research 8:
  32. Varad P, Bharat P, Nirbhay S, Saurav S, Pavan Z, Prashant P “Superdisintegrants used in Tablet.” International Journal of Pharmaceutical Research and Applications 8:1052
  33. Katiyar A, Singhyadav J, Gupta A, Singh J, Shri YA, Murti R Orodispersible Tablets: A Promising Approach Over Conventional Tablets.
  34. Al?in Yapar E (2014) Orally disintegrating tablets: An overview. J Appl Pharm Sci 4:118–125
  35. Ahire SB, Khairnar NN, Bairagi VA, Gangurde AB, Nikam SD, Hire M V (2024) A Review of Natural vs. Synthetic Disintegrants: Comparative Study and Future Perspectives. Journal of Chemical Health Risks 14:847–854
  36. Gandhi L, Akhtar S (2019) Comparative study on effect of natural and synthetic superdisintegrants in the formulation of orodispersible tablets. Journal of Drug Delivery and Therapeutics 9:507–513
  37. Dalimbe A, Pawar J, Bhosale S, Shinde N, Tupe R (2021) A REVIEW: NOVEL SUPERDISINTEGRANTS.
  38. Bhatt A (2023) A Review on Formulation and Evaluation of Orodispersible Tablets. Review Article | Pharmaceutical Sciences | OA Journal | MCI Approved | Index Copernicus 13:2321–3272
  39. Arun Rathod A, Pimpalshende PM (2025) Orodispersible Tablets in Modern Pharmaceutical Sciences: An Insight into Preparation and Clinical Applications. International Journal of Advanced Research in Science, Communication and Technology International Open-Access, Double-Blind, Peer-Reviewed, Refereed, Multidisciplinary Online Journal. https://doi.org/10.48175/568
  40. Aarti J, Sonali J, Ganesh D (2014) Orodispersible tablets: A comprehensive review. Res J Pharm Technol 7:368–375
  41. Halkett J (2007) Mouldings. Inwood Magazine 78:44–45
  42. Gupta AK, Mittal A, Jha PKK (2012) Fast Dissolving Tablet- A Review INTRODUCTION?: System?: 1:1–7
  43. Shoukri RA, Ahmed IS, Shamma RN (2009) In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets. European Journal of Pharmaceutics and Biopharmaceutics 73:162–171
  44. Formulation Development of Fast Dissolving Tablets. International Journal of Pharmaceutical Research and Applications 8:1575
  45. Ghourichay MP, Kiaie SH, Nokhodchi A, Javadzadeh Y (2021) Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and Perspectives. Biomed Res Int. https://doi.org/10.1155/2021/6618934
  46. Gupta A, Sharma D, Singh Yadav J, Shri *, Murti R (2022) Natural Superdisintegrant: A Key Ingredient for Orodispersible Dosage Form. J Pharm Negat Results 13:5150–5072
  47. Kiran Mahadeo Salunke, Sujata Umakant Veer, Yogesh Ankush Narute, Pratiksha Babusha Pawar, Amol Navnath Khedkar (2024) Various drugs used in oral disintegration tablet formulation. World Journal of Advanced Research and Reviews 24:459–476
  48. Biswas R, Mondal S, Ansari MA (2024) Orodispersible Tablets: A Novel Approach to Combat Dysphagia. Int J Pharm Sci Rev Res. https://doi.org/10.47583/ijpsrr.2024.v84i04.003
  49. Shobana K (2023) A Review on Orally Disintegrating Tablets.
  50. I. M, B. H, K. P (2022) Fast Dissolving Tablets: A Review. Asian Journal of Pharmacy and Technology 183–189
  51. Limenh LW, Tessema TA, Simegn W, Ayenew W, Bayleyegn ZW, Sendekie AK, Chanie GS, Fenta ET, Beyna AT, Kasahun AE (2024) Patients’ Preference for Pharmaceutical Dosage Forms: Does It Affect Medication Adherence? A Cross-Sectional Study in Community Pharmacies. Patient Prefer Adherence 18:753–766
  52. Hauber B, Hand M V., Hancock BC, Zarrella J, Harding L, Ogden-Barker M, Antipas AS, Watt SJ (2024) Patient Acceptability and Preferences for Solid Oral Dosage Form Drug Product Attributes: A Scoping Review. Patient Preference and Adherence 18:1281–1297
  53. Bitter I, Treuer T, Dilbaz N, Oyffe I, Ciorabai EM, Gonzalez SL, Ruschel S, Salburg J, Dyachkova Y (2010) Patients’ preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study. World Journal of Biological Psychiatry 11:894–903
  54. Choudhary V, Deepak S, Kulkarni G (2025) Oro Dispersible Tablets?: Recent Advancements , Challenges and Future Perspectives. 3:2471–2486
  55. Chinwala M (2020) Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs). Pharmacy 8:186
  56. Seal R, Chidambaram DrS (2024) A Comprehensive Review on Progress and Challenges in Technology of Orodispersible Tablets. International Journal of Pharmaceutical Research and Applications 09:475–483
  57. Anil Awdhutkar A, Suryawanshi SM (2025) Innovative Formulation Techniques for Orodispersible Tablets: A Review of Recent Advancements. International Journal of Emerging Technologies and Innovative Research (IJETIR). https://doi.org/10.48175/IJETIR-20251
  58. Parkash V, Maan S, Deepika, Yadav S, Hemlata H, Jogpal V (2011) Fast disintegrating tablets: Opportunity in drug delivery system. J Adv Pharm Technol Res 2:223–235
  59. Islam A, Haider SS, Reza MS (2011) Formulation and evaluation of orodispersible tablet of domperidone. Dhaka University Journal of Pharmaceutical Sciences 10:117–122

Reference

  1. Dey P, Maiti S (2010) Orodispersible tablets: A new trend in drug delivery. J Nat Sci Biol Med 1:2–5
  2. Pathak T, Gehalot N, Jain V, Mahajan S (2023) A Review on Orodispersible Tablet. International Journal of Pharmaceutical Sciences and Medicine 8:41–51
  3. Roshan K, Keerthy HS (2021) Orodispersible Tablets: A Compendious Review. Asian Journal of Pharmaceutical Research and Development 9:66–75
  4. Dey P, Maiti S (2010) Orodispersible tablets: A new trend in drug delivery. J Nat Sci Biol Med 1:2–5
  5. Pathak T, Gehalot N, Jain V, Mahajan S (2023) A Review on Orodispersible Tablet. International Journal of Pharmaceutical Sciences and Medicine 8:41–51
  6. Vishali T, Damodharan N (2020) Orodispersible tablets: A revew. Res J Pharm Technol 13:2522–2529
  7. Vishali T, Damodharan N (2020) Orodispersible tablets: A review. Res J Pharm Technol 13:2522–2529
  8. Rajput G, Kumar A (2013) A Review Article on Orodispersible tablet Formulation. THE PHARMA INNOVATION-JOURNAL 2:
  9. Snehal Bhanudas A, Raosaheb A, Bhanudas PR (2023) Orodispersible Tablets: A Popular Growing Technology INTRODUCTION.
  10. Desai N, Redfearn A, Macleod G, Tuleu C, Hanson B, Orlu M (2020) How do orodispersible tablets behave in an in vitro oral cavity model: A pilot study. Pharmaceutics 12:1–10
  11. Pallavi Mhaske, Punam Narwade, Dr Aijaz Sheikh, Dr. K. R. Biyani (2024) Orally Disintegrating Tablets: A Short Review. International Journal of Advanced Research in Science, Communication and Technology 129–136
  12. Juhi B, Manoj L (2022) A Review on Orodispersible Tablet by Using Hibiscus rosa sinesis as Natural Superdisintegrant. International Journal of Pharmaceutical Sciences and Medicine 7:59–69
  13. Sharma P (2024) OVERVIEW OF ORAL DISPERSIBLE TABLETS Preeti Sharma Ram Gopal College of Pharmacy, Sultanpur, Gurugram - 122506, Haryana, India. 15:1340–1345
  14. Zinkal P, Rahul P, Patel KR, Patel MR A Review: Formulation of Fast Dissolving Tablet.
  15. Ikam VK, Kotade KB, Gaware VM, Dolas RT, Dhamak KB, Somwanshi SB, Khadse AN, Kashid VA, Nikam VK MOUTH DISSOLVIIG TABLETS?: AA OVERVIEW.
  16. Maner NA*, Shinde A D (2022) Issue:4 Citation.
  17. Katiyar A, Singhyadav J, Gupta A, Singh J, Shri YA, Murti R Orodispersible Tablets: A Promising Approach Over Conventional Tablets.
  18. Wiedey R, Kokott M, Breitkreutz J (2021) Orodispersible tablets for pediatric drug delivery: current challenges and recent advances. Expert Opin Drug Deliv 18:1873–1890
  19. Zhang L, Aloia M, Pielecha-Safira B, Lin H, Rajai PM, Kunnath K, Davé RN (2018) Impact of Superdisintegrants and Film Thickness on Disintegration Time of Strip Films Loaded With Poorly Water-Soluble Drug Microparticles. J Pharm Sci 107:2107–2118
  20. Kumar A, Saharan VA (2017) Salbutamol Sülfat?n Oral Da??lan Tabletlerinin Formülasyonu ve De?erlendirilmesi: Süper Da??t?c?lar?n Farkl? Oranlar?n?n Kar??la?t?rmal? Çal??mas?. Turk J Pharm Sci 14:40–48
  21. Arun Rathod A, Pimpalshende PM (2025) Orodispersible Tablets in Modern Pharmaceutical Sciences: An Insight into Preparation and Clinical Applications. International Journal of Advanced Research in Science, Communication and Technology International Open-Access, Double-Blind, Peer-Reviewed, Refereed, Multidisciplinary Online Journal. https://doi.org/10.48175/568
  22. Dey P, Maiti S (2010) Orodispersible tablets: A new trend in drug delivery. J Nat Sci Biol Med 1:2–5
  23. Aphale K, Patil S (2024) Natural Polymers: Use as Superdisintegrants. Int J Pharm Sci Rev Res. https://doi.org/10.47583/ijpsrr.2024.v84i07.011
  24. Kumari M S, Kaza R (2019) Novel Natural Superdisintegrants: An Updated Review.
  25. Metta S, Sahoo SK (2024) Green Alternatives in Drug Delivery: Harnessing the Potential of Natural Superdisintegrants for Enhanced Pharmaceutical Performance. African Journal of Pharmaceutical Sciences 4:1–20
  26. Suryadevara V, Lankapalli SR, Danda LH, Pendyala V, Katta V (2017) Studies on jackfruit seed starch as a novel natural superdisintegrant for the design and evaluation of irbesartan fast dissolving tablets. Integr Med Res 6:280–291
  27. Draksiene G, Venclovaite B, Pudziuvelyte L, Ivanauskas L, Marksa M, Bernatoniene J (2021) pharmaceutics Natural Polymer Chitosan as Super Disintegrant in Fast Orally Disintegrating Meloxicam Tablets: Formulation and Evaluation. https://doi.org/10.3390/pharmaceutics
  28. Mohamed A (2025) Natural Disintegrants in Pharmaceutical Formulations. Journal of Pharmacological and Pharmaceutical Research 2:1
  29. Joseph F, Premaletha K (2021) Natural Superdisintegrants for the Formulation of Orally Disintegrating Tablets. International Journal of Research and Review 8:123–128
  30. Priya Immadi H, Lakshmi Jyothirmai Kala S, raoK S, Rao Nr (2017) Comparative Study of Natural and Synthetic Superdisintegrants in the Formulation of Oral Fast Disintegrating Tablets Using Levofloxacin HCl as Model Drug.
  31. Kandav G, Barik P (2023) A review on plant based superdisintegrants. International Journal of Scientific Development and Research 8:
  32. Varad P, Bharat P, Nirbhay S, Saurav S, Pavan Z, Prashant P “Superdisintegrants used in Tablet.” International Journal of Pharmaceutical Research and Applications 8:1052
  33. Katiyar A, Singhyadav J, Gupta A, Singh J, Shri YA, Murti R Orodispersible Tablets: A Promising Approach Over Conventional Tablets.
  34. Al?in Yapar E (2014) Orally disintegrating tablets: An overview. J Appl Pharm Sci 4:118–125
  35. Ahire SB, Khairnar NN, Bairagi VA, Gangurde AB, Nikam SD, Hire M V (2024) A Review of Natural vs. Synthetic Disintegrants: Comparative Study and Future Perspectives. Journal of Chemical Health Risks 14:847–854
  36. Gandhi L, Akhtar S (2019) Comparative study on effect of natural and synthetic superdisintegrants in the formulation of orodispersible tablets. Journal of Drug Delivery and Therapeutics 9:507–513
  37. Dalimbe A, Pawar J, Bhosale S, Shinde N, Tupe R (2021) A REVIEW: NOVEL SUPERDISINTEGRANTS.
  38. Bhatt A (2023) A Review on Formulation and Evaluation of Orodispersible Tablets. Review Article | Pharmaceutical Sciences | OA Journal | MCI Approved | Index Copernicus 13:2321–3272
  39. Arun Rathod A, Pimpalshende PM (2025) Orodispersible Tablets in Modern Pharmaceutical Sciences: An Insight into Preparation and Clinical Applications. International Journal of Advanced Research in Science, Communication and Technology International Open-Access, Double-Blind, Peer-Reviewed, Refereed, Multidisciplinary Online Journal. https://doi.org/10.48175/568
  40. Aarti J, Sonali J, Ganesh D (2014) Orodispersible tablets: A comprehensive review. Res J Pharm Technol 7:368–375
  41. Halkett J (2007) Mouldings. Inwood Magazine 78:44–45
  42. Gupta AK, Mittal A, Jha PKK (2012) Fast Dissolving Tablet- A Review INTRODUCTION?: System?: 1:1–7
  43. Shoukri RA, Ahmed IS, Shamma RN (2009) In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets. European Journal of Pharmaceutics and Biopharmaceutics 73:162–171
  44. Formulation Development of Fast Dissolving Tablets. International Journal of Pharmaceutical Research and Applications 8:1575
  45. Ghourichay MP, Kiaie SH, Nokhodchi A, Javadzadeh Y (2021) Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and Perspectives. Biomed Res Int. https://doi.org/10.1155/2021/6618934
  46. Gupta A, Sharma D, Singh Yadav J, Shri *, Murti R (2022) Natural Superdisintegrant: A Key Ingredient for Orodispersible Dosage Form. J Pharm Negat Results 13:5150–5072
  47. Kiran Mahadeo Salunke, Sujata Umakant Veer, Yogesh Ankush Narute, Pratiksha Babusha Pawar, Amol Navnath Khedkar (2024) Various drugs used in oral disintegration tablet formulation. World Journal of Advanced Research and Reviews 24:459–476
  48. Biswas R, Mondal S, Ansari MA (2024) Orodispersible Tablets: A Novel Approach to Combat Dysphagia. Int J Pharm Sci Rev Res. https://doi.org/10.47583/ijpsrr.2024.v84i04.003
  49. Shobana K (2023) A Review on Orally Disintegrating Tablets.
  50. I. M, B. H, K. P (2022) Fast Dissolving Tablets: A Review. Asian Journal of Pharmacy and Technology 183–189
  51. Limenh LW, Tessema TA, Simegn W, Ayenew W, Bayleyegn ZW, Sendekie AK, Chanie GS, Fenta ET, Beyna AT, Kasahun AE (2024) Patients’ Preference for Pharmaceutical Dosage Forms: Does It Affect Medication Adherence? A Cross-Sectional Study in Community Pharmacies. Patient Prefer Adherence 18:753–766
  52. Hauber B, Hand M V., Hancock BC, Zarrella J, Harding L, Ogden-Barker M, Antipas AS, Watt SJ (2024) Patient Acceptability and Preferences for Solid Oral Dosage Form Drug Product Attributes: A Scoping Review. Patient Preference and Adherence 18:1281–1297
  53. Bitter I, Treuer T, Dilbaz N, Oyffe I, Ciorabai EM, Gonzalez SL, Ruschel S, Salburg J, Dyachkova Y (2010) Patients’ preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study. World Journal of Biological Psychiatry 11:894–903
  54. Choudhary V, Deepak S, Kulkarni G (2025) Oro Dispersible Tablets?: Recent Advancements , Challenges and Future Perspectives. 3:2471–2486
  55. Chinwala M (2020) Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs). Pharmacy 8:186
  56. Seal R, Chidambaram DrS (2024) A Comprehensive Review on Progress and Challenges in Technology of Orodispersible Tablets. International Journal of Pharmaceutical Research and Applications 09:475–483
  57. Anil Awdhutkar A, Suryawanshi SM (2025) Innovative Formulation Techniques for Orodispersible Tablets: A Review of Recent Advancements. International Journal of Emerging Technologies and Innovative Research (IJETIR). https://doi.org/10.48175/IJETIR-20251
  58. Parkash V, Maan S, Deepika, Yadav S, Hemlata H, Jogpal V (2011) Fast disintegrating tablets: Opportunity in drug delivery system. J Adv Pharm Technol Res 2:223–235
  59. Islam A, Haider SS, Reza MS (2011) Formulation and evaluation of orodispersible tablet of domperidone. Dhaka University Journal of Pharmaceutical Sciences 10:117–122

Photo
Md. Parvej Alam
Corresponding author

Department of Pharmaceutics, Himalayan Pharmacy Institute

Photo
Wonshikha Rai
Co-author

Department of Pharmaceutics, Himalayan Pharmacy Institute

Photo
Dr. Arnab Bagchi
Co-author

Department of Pharmaceutics, Himalayan Pharmacy Institute

Md. Parvej Alam, Wonshikha Rai, Dr. Arnab Bagchi, Advances and Perspectives in Orodispersible Tablets: Natural and Synthetic Superdisintegrants for Enhanced Drug Delivery, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 3, 1643-1665. https://doi.org/10.5281/zenodo.19045660

More related articles
Next Generation Incretin Therapies in Obesity: Evo...
Sonale S, Gowtham Arumugam , Revanth R...
A Review on Diuretic Activity, Pharmacological Use...
Mohd Sahil, Sudhir Kumar, Kamal Kishore...
Formulation and Evaluation of Polyherbal Shampoo...
Priyanka Bandichhode, Predeep Chabukswar, Shruti Narayankar, Kris...
Formulation and Evaluation of Natural Herbal Face Wash Tablets Containing Sandal...
Pradeep Chabukswar, Priyanka Bandichhode, Shivani Biskite, Deepak Bhosale...
A Research on Formulation and Evaluation of Herbal Soap...
Gurude Sneha, Shivraj Suryawanshi, Hambire Shradha, Gudde Saraswati, Ghevare Omkar, Gangapure Sakshi...
Virtual Screening of Bioactive Constituents of Lagenaria siceraria as Potential ...
Dinesh Kawade, Gun Chourasia, Shashwati Motghare, Dipak Rinait, Alpana Asnani...
More related articles
Formulation and Evaluation of Polyherbal Shampoo...
Priyanka Bandichhode, Predeep Chabukswar, Shruti Narayankar, Krishnamurthy Kamalapurkar...
Formulation and Evaluation of Polyherbal Shampoo...
Priyanka Bandichhode, Predeep Chabukswar, Shruti Narayankar, Krishnamurthy Kamalapurkar...